The term “chromosome” is used to refer to a nucleic acid molecule that is the repository of genetic information in a virus, a bacterium, an archaeon, a eukaryotic cell, or an organelle. It also refers to the densely colored bodies seen in the nuclei of dye-stained eukaryotic cells undergoing mitosis, as visualized using a light microscope.
The eukaryotic cell cycle produces remarkable changes in the structure of chromosomes (Fig. 24-22). In nondividing eukaryotic cells (in the G0 phase) and those in interphase (G1, S, and G2), the chromosomal material, chromatin, is amorphous. In the S phase of interphase, the DNA in this amorphous state replicates, each chromosome producing two sister chromosomes (called sister chromatids) that remain associated with each other after replication is complete. The chromosomes become much more condensed during prophase of mitosis, taking the form of a species-specific number of well-defined pairs of sister chromatids (Fig. 24-5).
Chromatin consists of fibers containing protein and DNA in approximately equal proportions (by mass), along with a significant amount of associated RNA. The DNA in the chromatin is very tightly associated with proteins called histones, which package and order the DNA into structural units called nucleosomes (Fig. 24-23). Also found in chromatin are many nonhistone proteins, some of which help maintain chromosome structure and others that regulate the expression of specific genes (Chapter 28). Beginning with nucleosomes, eukaryotic chromosomal DNA is packaged into a succession of higher-order structures that ultimately yield the compact chromosome seen with the light microscope. We now turn to a description of this structure in eukaryotes and compare it with the packaging of DNA in bacterial cells.
Found in the chromatin of all eukaryotic cells, histones have molecular weights between 11,000 and 21,000 and are very rich in the basic amino acids arginine and lysine (together these make up about one-fourth of the amino acid residues). All eukaryotic cells have five major classes of histones, differing in molecular weight and amino acid composition (Table 24-5). The H3 histones are nearly identical in amino acid sequence in all eukaryotes, as are the H4 histones, suggesting strict conservation of their functions. For example, only 2 of 102 amino acid residues differ between the H4 histone molecules of peas and cows, and only 8 differ between the H4 histones of humans and yeast. Histones H1, H2A, and H2B show less sequence similarity across eukaryotic species.
Histones | Molecular weight | Number of amino acid residues | Content of basic amino acids (% of total) | |
---|---|---|---|---|
Lys | Arg | |||
H1a |
21,130 |
223 |
29.5 |
11.3 |
H2Aa |
13,960 |
129 |
10.9 |
19.3 |
H2Ba |
13,774 |
125 |
16.0 |
16.4 |
H3 |
15,273 |
135 |
19.6 |
13.3 |
H4 |
11,236 |
102 |
10.8 |
13.7 |
aThe sizes of these histones vary somewhat from species to species. The numbers given here are for bovine histones. |
Each type of histone is subject to enzymatic modification by methylation, acetylation, ADP-ribosylation, phosphorylation, glycosylation, SUMOylation, or ubiquitination (p. 216 and Fig. 6-38). Such modifications affect the net electric charge, shape, and other properties of histones, as well as the structural and functional properties of the chromatin. The modifications play a role in the regulation of transcription and in chromatin structure at different stages of the cell cycle.
In addition, eukaryotes generally have several variant forms of certain histones, most notably histones H2A and H3, described in more detail below. The variant forms, along with their modifications, have specialized roles in DNA metabolism.
The eukaryotic chromosome depicted in Figure 24-5 represents the compaction of a DNA molecule about μm long into a cell nucleus that is typically 5 to 10 μm in diameter. This 10,000-fold compaction is achieved by means of several levels of highly organized folding. Subjection of chromosomes to treatments that partially unfold them reveals a structure in which the DNA is bound tightly to beads of protein, often regularly spaced. The beads in this “beads-on-a-string” arrangement are complexes of histones and DNA. The bead plus the connecting DNA that leads to the next bead form the nucleosome, the fundamental unit of organization on which the higher-order packing of chromatin is built (Fig. 24-24). The bead of each nucleosome contains eight histone molecules: two copies each of H2A, H2B, H3, and H4. The spacing of the nucleosome beads provides a repeating unit typically of about 200 bp, of which 146 bp are bound tightly around the eight-part histone core and the remainder serve as linker DNA between nucleosome beads. Histone H1 binds to the linker DNA. Brief treatment of chromatin with enzymes that digest DNA causes the linker DNA to degrade preferentially, releasing histone particles containing 146 bp of bound DNA that is protected from digestion.
Researchers have crystallized nucleosome cores obtained in this way, and x-ray diffraction analysis reveals a particle made up of the eight histone molecules with the DNA wrapped around the core in the form of a left-handed solenoidal supercoil (Fig. 24-24; see also Fig. 24-21). Extending out from the nucleosome core are the amino-terminal tails of the histones, which are intrinsically disordered (Fig. 24-24d). Most of the histone modifications occur in these tails. The tails play a key role in forming contacts between nucleosomes in the chromatin (Fig. 24-24e). As the nucleosomes are approximately 10 to 11 nm in diameter, this simple beads-on-a-string structure is sometimes called the 10 nm fiber.
A close inspection of the nucleosome structure reveals why eukaryotic DNA is underwound even though eukaryotic cells lack enzymes that underwind DNA. Recall that the solenoidal wrapping of DNA in nucleosomes is but one form of supercoiling that can be taken up by underwound (negatively supercoiled) DNA. The tight wrapping of DNA around the histone core requires the removal of about one helical turn in the DNA. When the protein core of a nucleosome binds in vitro to a relaxed closed-circular DNA, the binding introduces a negative supercoil. Because this binding process does not break the DNA or change the linking number, the formation of a negative solenoidal supercoil must be accompanied by a compensatory positive supercoil in the unbound region of the DNA (Fig. 24-25). As mentioned earlier, eukaryotic topoisomerases can relax positive supercoils. Relaxing the unbound positive supercoil leaves the negative supercoil fixed (through its binding to the nucleosome’s histone core) and results in an overall decrease in linking number. Indeed, topoisomerases have proved necessary for assembling chromatin from purified histones and closed-circular DNA in vitro.
Another factor that affects the binding of DNA to histones in nucleosome cores is the sequence of the bound DNA. Histone cores do not bind at random positions on the DNA; rather, some locations are more likely to be bound than others. This positioning is not fully understood, but in some cases it seems to depend on a local abundance of base pairs in the DNA helix where it is in contact with the histones (Fig. 24-26). A cluster of two or three base pairs facilitates the compression of the minor groove that is needed for the DNA to wrap tightly around the nucleosome’s histone core. Nucleosomes bind particularly well to sequences where AA or AT or TT dinucleotides are staggered at 10 bp intervals, an arrangement that can account for up to 50% of the positions of bound histones in vivo.
Nucleosome cores are deposited on DNA during replication or following other processes that require a transient displacement of nucleosomes. Other, nonhistone proteins are required for the positioning of some nucleosome cores. In several organisms, certain proteins bind to a specific DNA sequence and facilitate the formation of a nucleosome core nearby. Nucleosome cores seem to be deposited stepwise. A tetramer of two H3 and two H4 histones binds first, followed by two H2A–H2B dimers. The incorporation of nucleosomes into chromosomes after chromosomal replication is mediated by a complex of histone chaperones conserved in all eukaryotes and described here for the yeast system. These include the proteins CAF1 (chromatin assembly factor 1), RTT106 and RTT109 (regulation of Ty1 transposition), and ASF1 (anti-silencing factor 1). ASF1 binds to newly synthesized H3–H4 dimers and facilitates RTT109-mediated acetylation at (K56) of histone H3 (H3K56). The H3K56 modification increases the affinity of H3 for CAF1 and RTT, which in turn promote the deposition of H3-containing histone complexes on the DNA after replication. CAF1 binds directly to a key component of the replication complex called PCNA (see Chapter 25), so that nucleosome deposition is closely coordinated with replication. Some of the same histone chaperones, or different ones, may help assemble nucleosomes after DNA repair, transcription, or other processes.
Histone exchange factors permit the substitution of histone variants for core histones in contexts other than postreplication. Proper placement of these variant histones is important. Studies show that mice lacking one of the variant histones die as early embryos (Box 24-1). Precise positioning of nucleosome cores also plays a role in the expression of some eukaryotic genes (Chapter 28).
Wrapping of DNA around a nucleosome core compacts the DNA length about sevenfold. The overall compaction in a chromosome, however, is greater than 10,000-fold — ample evidence for even higher orders of structural organization. The condensation does not follow a rigid organization, but it is also not random and occurs so as to avoid the formation of knots.
The higher levels of folding are not yet fully understood, but certain regions of DNA seem to associate with a chromosomal scaffold (Fig. 24-27) that contains many proteins. Given the need to fold and compact the chromosome without creating knots, topoisomerase II is one of the most abundant proteins in the chromosome, further emphasizing the relationship between DNA underwinding and chromatin structure. Topoisomerase II is so important to the maintenance of chromatin structure that inhibitors of this enzyme can kill rapidly dividing cells. Several drugs used in cancer chemotherapy are topoisomerase II inhibitors that allow the enzyme to promote strand breakage but not the resealing of the breaks (Box 24-2, p. 906).
Part a shows an electron micrograph chromosome with two short arms extending to the right and two longer arms extending to the left. The arms have a fuzzy appearance. Part b is a micrograph with much of the background filled with loops of D N A and two roughly horizontal darker structures with many branches running across the top labeled chromosomal scaffold. Part c is a micrograph showing loops of D N A that can be traced back to where they attach to the scaffold on the left. The micrograph is about 6 micrometers in length and a labeled loop that extends back to the scaffold is of similar length but bends upward before running horizontally to the left. All data are approximate.
Curing Disease by Inhibiting Topoisomerases
The topological state of cellular DNA is intimately connected with its function. Without topoisomerases, cells cannot replicate or package their DNA, or express their genes — and they die. Inhibitors of topoisomerases have therefore become important pharmaceutical agents, targeted at infectious agents and malignant cells.
Two classes of bacterial topoisomerase inhibitors have been developed as antibiotics. The coumarins, including novobiocin and coumermycin A1, are natural products derived from Streptomyces species. They inhibit the ATP binding of the bacterial type II topoisomerases, DNA gyrase and topoisomerase IV. These antibiotics are not often used to treat infections in humans, but research continues to identify clinically effective variants.
The quinolone antibiotics, also inhibitors of bacterial DNA gyrase and topoisomerase IV, first appeared in 1962 with the introduction of nalidixic acid. This compound had limited effectiveness and is no longer used clinically in the United States, but the continued development of this class of drugs eventually led to the introduction of the fluoroquinolones, exemplified by ciprofloxacin (Cipro). The quinolones act by blocking the last step of the topoisomerase reaction, the resealing of the DNA strand breaks. Ciprofloxacin is a broad-spectrum antibiotic. It is one of the few antibiotics reliably effective in treating anthrax infections and is considered a valuable agent in protection against possible bioterrorism. Quinolones are selective for the bacterial topoisomerases, inhibiting the eukaryotic enzymes only at concentrations several orders of magnitude greater than the therapeutic doses.
Nalidixic acid: A six-membered ring has double bonds at the upper left, lower left and right sides; N substituted for C at the bottom vertex; a lower left vertex bonded to C H 3; and double bond at the right side shared with an adjacent six-membered ring with a double bond at its right side; N substituted for C at its bottom vertex and further bonded to C H 3; a top vertex double bonded to O; and an upper right vertex bonded to C double bonded to O above and bonded to O H to the lower right. Ciprofloxacin: A six-membered ring has N substituted for C at the lower left vertex and bonded to H and N substituted for C at the upper right vertex and bonded to the lower left vertex of a benzene ring with its upper left vertex bonded to F and a double bond at its right side shared with the left side of an adjacent right-hand six-membered ring. The right-hand six-membered ring has a double bond at its right side, N substituted for C at its bottom vertex and bonded to the top vertex of a three-carbon ring below, a top vertex double bonded to O, and an upper right vertex bonded to C double bonded to O above and bonded to O minus to the lower right.
Some of the most important chemotherapeutic agents used in cancer treatment are inhibitors of human topoisomerases. Topoisomerases are generally present at elevated levels in tumor cells, and agents targeted to these enzymes are much more toxic to the tumors than to most other tissue types. Inhibitors of both type I and type II topoisomerases have been developed as anticancer drugs.
Topotecan is a six-carbon ring with double bonds at its upper and lower left sides; a lower left vertex bonded to O H; a bottom vertex bonded to C H 2 bonded to N further bonded to 2 C H 3; and double bond at its right side shared with a six-membered ring to the right. This six-membered ring has double bonds at its left, upper right, and lower right sides; N substituted for C at the top vertex; and a right side shared with the left side of an adjacent five-membered ring with N at its lower right vertex. This five-membered ring shares its right side with an adjacent six-membered ring. The six-membered ring has N at its lower left vertex shared with the adjacent five-membered ring, a double bond at its upper left side, a bottom vertex double bonded to O, and a double bond at its right side shared with the left side of an adjacent six-membered ring that has O substituted for C at its lower right vertex, an upper right vertex double bonded to O, and a top vertex bonded to O H and to C H 2 C H 3.
Camptothecin, isolated from a Chinese ornamental tree and first tested clinically in the 1970s, is an inhibitor of eukaryotic type I topoisomerases. Clinical trials indicated limited effectiveness, despite its early promise in preclinical work on mice. However, two effective derivatives, irinotecan (Campto) and topotecan (Hycamtin) — used to treat colorectal cancer and ovarian cancer, respectively — were developed in the 1990s. All of these drugs act by trapping the topoisomerase-DNA complex in which the DNA is cleaved, inhibiting religation.
Etoposide has a benzene ring bonded to O C H 3 to the lower left and right, bonded to O H below, and with a top vertex bonded to the bottom vertex of a six-membered ring above that is bonded to a right-hand five-membered ring and a left-hand benzene ring. The five-membered ring has O at its upper left vertex and a lower left vertex double bonded to O. The six-membered ring to its left, bonded to the benzene ring below, and sharing its left side with a left-hand benzene ring, has a top vertex bonded to O bonded to the lower right vertex of a chair confirmation of a six-membered ring with O substituted for C at the upper right vertex, a lower center vertex down-equatorial bonded to O H, a lower left vertex down-equatorial bonded to O H, and an upper left side shared with the lower right side of a chair confirmation of a six-membered ring above with O substituted for C at its upper center and lower left vertices and an upper left vertex bonded to H and C H 3. The left-hand benzene ring that shares its right side with the six-membered ring that shares its right side with a five-membered ring to the right and is bonded to a benzene ring below shares its left side with the right side of a five-membered ring. This left-hand five-membered ring has O substituted for C at its lower left and top vertices.
The human type II topoisomerases are targeted by a variety of antitumor drugs, including doxorubicin (Adriamycin), etoposide (Etopophos), and ellipticine. Doxorubicin, effective against several kinds of human tumors, is an anthracycline in clinical use. Most of these drugs stabilize the covalent topoisomerase-DNA (cleaved) complex.
All of these anticancer agents generally increase the levels of DNA damage in the targeted, rapidly growing tumor cells. However, noncancerous tissues can also be affected, leading to a more general toxicity and unpleasant side effects that must be managed during therapy. As cancer therapies become more effective and survival statistics for cancer patients improve, the independent appearance of new tumors is becoming a greater problem. In the continuing search for new cancer therapies, topoisomerases are likely to remain prominent targets for research.
There are additional layers of organization in the eukaryotic nucleus. Just before cell division during mitosis, chromosomes can be seen as highly condensed and organized structures (Figure 24-28a). During interphase, chromosomes appear dispersed (Fig. 24-28b, top), but they do not meander randomly in nuclear space (Fig. 24-28b, bottom). Each chromosome appears to be organized with two sets of compartments, one set that is transcriptionally active and the other that is transcriptionally inactive. The level of chromatin condensation is reduced in the transcriptionally active compartments. The highly condensed DNA in transcriptionally inactive regions or in regions lacking genes is also called heterochromatin. Within each compartment, large segments of DNA are organized in loops called topologically associating domains, or TADs. The TADs, which typically average about 800,000 bp, are often bordered by DNA sites recognized by the CCCTC-binding factor (CTCF). The binding by CTCF brings together sites that are otherwise quite distant in the linear DNA sequence, tethering the base of the loop (Fig. 24-28c).
Part a shows a cell with chromosomes at the top and bottom ends. The chromosome arms extend toward the center and bends connecting the arms face toward the poles. Part b shows two images of interphase nuclei against dark backgrounds. The top illustration shows a blue cell against a dark background with multiple darker regions and a large dark region toward the lower left. The bottom image is more irregular in shape, has a dark spot at the left side, and has bright green regions at the lower right and bottom sides. Part c shows a blue strand of D N A that forms regions with multiple back-and-forth bends connected by strands. Some of these regions are yellow and are labeled inactive compartments and others are green and are labeled active compartments. There are many yellow inactive compartments along the right side and many green active compartments to their left. Beginning at the upper left, the D N A runs through compartments as follows: inactive, active, inactive, inactive, active, inactive, inactive, active, inactive, active, inactive, inactive, inactive, active, inactive, active, inactive. A close-up of one inactive compartment shows that the D N A molecule begins at the upper right by passing through a dark segment beneath a blue oval labeled T A D, loops around, and then exits by running through a similar dark segment beneath a blue oval labeled C T C F binding sites.
Another important component defining the structure of chromosomes is RNA, particularly a class of RNAs called long noncoding RNAs (lncRNAs). RNA has the potential to take up a variety of structures (see Chapter 8), and can interact with DNA, proteins, or other RNA molecules. The lncRNAs, as the name implies, are functional RNAs, generally over 200 nucleotides long, that do not necessarily encode proteins. Many lncRNAs are now known and more are being discovered rapidly. Many of them provide a scaffold for proteins that both bind to the RNA and affect chromosome structure and function. Some proteins that bind to lncRNAs also have binding sites on DNA, and the RNAs provide a link that tethers distant parts of the chromosome together (Fig. 24-29). Other proteins that bind to lncRNAs help to position nucleosomes, modify histones, methylate DNA at various locations to alter gene transcription, and generally affect chromosome structure in many different ways. Some well-studied examples include particular lncRNAs that play a major role in X chromosome inactivation in mammals (Box 24-3).
Part a shows multiple clumps of one to four beige structures that are roughly sphere-shaped. Blue strands of D N A run against each one. Green strands connect openings in one beige structure with openings on other beige structures. This produces interactions between beige structures located at different places on D N A. Part b shows two strands of D N A that bend to run vertically along the right side of the illustration. Halfway up, the two strands are separated and a green strand begins that runs to the right. There are four beige structures to the right that vary in shape and that have cutouts of varying shapes. The green strand folds into one opening and then out again, forming bonds between the two halves, then continues to folding into other openings in the beige structure while forming bonds between its two halves when they are close together.
X Chromosome Inactivation by an lncRNA: Preventing Too Much of a Good (or Bad) Thing
In higher eukaryotes, the Y chromosome contains only a few genes. The X chromosome, in contrast, often contains more than a thousand genes, many essential for cell function and organismal development. Males have just one X chromosome, whereas females have two. Females thus could end up with a double dose of gene products, leading to a variety of potentially toxic outcomes. Mechanisms of gene dosage compensation vary among different groups of eukaryotes. In most mammals, dosage compensation is accomplished by X chromosome inactivation, randomly affecting just one of the two X chromosomes in a given cell. The effects of this can be seen in calico cats, all of which are female. Fur pigmentation genes are found on the X chromosome. When a cat inherits chromosomes with different pigmentation alleles on its two X chromosomes, its coloration patterns reflect the random inactivation of one or the other X chromosome in different sets of cells.
An lncRNA called Xist (X-inactive specific transcript) is uniquely expressed from its gene on the inactive X chromosome. Xist is approximately 17,000 nucleotides long, encodes no proteins, and is expressed only in cells with two X chromosomes (not in males). Xist is an essential component of the X inactivation process. This lncRNA interacts with many proteins and transcription factors (Fig. 1). As it migrates in the region immediately proximal to the gene from which it is transcribed, Xist gradually encompasses more and more DNA as that X chromosome undergoes a major condensation, giving rise to the inactive form called a Barr body.
Part a shows a long blue piece of double-stranded D N A that passes through a ribosome so that green l n c R N A can be transcript. L n c R N A forms loops joined together by bonds between nucleotides in adjacent strands. Part b shows D N A passing through the same ribosome as green pieces of X ist R N A are produced. Green pieces of X ist R NA form loops that fit into opening in round beige structures distributed around the D N A throughout the illustration. Part c shows the top of a nuclear envelop with strands of D N A beneath. A region is highlighted in yellow and contains bright blue D N A labeled inactive X chromosome. A small red piece of this bright blue D N A is labeled italicized X ist end italics gene.
The active X chromosome also transcribes the gene that produces Xist, but it does so in the opposite direction to produce a longer lncRNA called Tsix (Xist spelled backward). Tsix is synthesized using a different RNA polymerase binding site (promoter; Chapter 26) and is 40,000 nucleotides long. A large part of Tsix is perfectly complementary to Xist, and it antagonizes the function of any Xist that may appear near the active X chromosome.
Random X inactivation occurs in the cells of a female embryo long before birth. The processes that initiate the inactivation of one, but not both, of the X chromosomes in a particular cell are still being elucidated.
The entire structure of each chromosome is constrained within a subnuclear domain called a chromosome territory (Fig. 24-30). There is little or no intermingling of chromosomal DNA in different territories. The exact location of chromosome territories varies from cell to cell in an organism, but some spatial patterns are evident. Some chromosomes have a higher density of genes than others (for example, human chromosomes 1, 16, 17, 19, and 22), and these tend to have territories in the center of the nucleus. Chromosomes with more heterochromatin tend to be located on the nuclear periphery. Spaces between chromosomes are often sites where transcriptional machinery and transcriptionally active genes on adjacent chromosomes are concentrated.
An oval nucleus is shown with nuclear pores located around the outside. Each nuclear pore forms a channel with wavy threads extending out from the nucleus. A blue roughly spherical structure near the center is labeled nucleolus. Different regions of the nucleus are shaded in different colors and these are labeled chromosome territories. Lighter areas between these territories are labeled interchromatin compartments. There is a brown territory at the upper left a yellow territory to the upper right, a vertical dark green territory extending down where they meet, a light green territory beneath and slightly overlapping the yellow territory, an orange territory to the right, a dark orange territory in the upper right corner, a pink territory at the lower right side, a purple territory at the bottom right, a dark purple region to the lower left, and a light blue region at the lower left. Lighter areas between these territories are labeled interchromatin compartments.
SMC proteins (structural maintenance of chromosomes), the third major class of chromatin protein in addition to the histones and topoisomerases, are responsible for maintaining the structure and integrity of chromosomes following replication. The primary structure of SMC proteins consists of five distinct domains (Fig. 24-31a). The amino- and carboxyl-terminal globular domains, N and C, each of which contains part of an ATP-hydrolytic site, are connected by two regions of α-helical coiled-coil motifs (see Fig. 4-10) joined by a hinge domain. The proteins are generally dimeric, forming a V-shaped complex that is thought to be tied together through the protein’s hinge domains. One N domain and one C domain come together like tweezers to form a complete ATP-hydrolytic site at each free end of the V (Fig. 24-31b).
Part a shows a green piece labeled head and C that resembles the lower left quarter of a circle with a slight circular cutout. This is connected by a long, wavy, vertical alpha-helical connector to a half-circle with a circular cutout that has a lighter top half and a darker bottom half with the line separating them labeled as hinge. Another wavy alpha-helical connector extends down to a dark quarter circle with a slight cutout labeled head and N. Part b shows a circle at the top with a circular opening in the center. The circle has four parts with a light green upper left part, a dark green lower left part, a light purple upper right part, and a dark purple lower left part. Two intertwined strands run vertically down the left and right sides and are labeled coiled coils. The left-hand strand is green and the right-hand strand is purple. The green strand ends at a half-circle with a dark green top labeled N and a light green bottom labeled C. A cutout between them forms a half circle. The purple strand ends at a half circle with a dark purple top labeled C and a light purple bottom labeled N. A cutout between them forms a half-circle. These half-circle openings are labeled A T P-binding sites. Part c shows the structures of four S M C proteins. Bacterial S M C: A blue oval at the top has a vertical line down its center and strands labeled S M C that curve down the left and right to each end at the rounded tops of half-circles. Each half-circle is divided by a vertical line and has a gray oval beneath that connects horizontally to another gray oval that connects to a sphere. A gray line curves above to connect the gray ovals as well. The spheres from the left and right are close together at the bottom center. Cohesin: Similar to bacterial S M C except that the left half is purple with a strand labeled S M C 1 and the right half is green with a strand labeled S M C 3. S M C 1 ends at a purple half circle that joins to an orange oval. S M C 3 ends at a green half circle that joins to an orange ova. These ovals are labeled kleisin family connector proteins. A curved strand connecting the orange ovals meets the top of a larger white oval below. Codensin: Similar to cohesion except that the left side is purple and labeled S M C 2 and the right side is red and labeled S M C 4. S M C 2 ends in a purple half-circle that meets a blue oval and S M C 4 ends in a red half-circle that meets a blue oval. These ovals are labeled kleisin family connector proteins. A black strand connects the two blue ovals and each is connected to a partial circle below. These circles have cutouts that form a founded opening at the upper center where they join. S M C 5 – S M C 6 is similar to condensing except that the left side is gold and labeled S M C 5 and the right side is orange and labeled S M C 6. A translucent blue vertical oval runs along the bottom part of S M C 5. S M C 5 ends at the left half of a gold oval and S M C 6 ends at the right half of an orange oval. This oval is divided into four parts by a vertical line and a horizontal line. Part d shows eight micrographs of S M C dimers, with four across the top an four across the bottom. Each microgram is 70 micrometers in length. Top row: The left-hand micrograph shows a dark line running diagonally from lower right to upper left; the second micrograph shows dark spots at the top and bottom with curved lines between them forming an oval opening; the third microgram downs a dark bottom and lines that separate to dark spots to the left and right at the top; and the fourth micrograph shows a dark spot at the bottom with lines that curve up to the left and right and come close to meeting at the top. Bottom row: The left-hand micrograph shows an oval structure; the second micrograph shows a line that splits to two dark dots to the upper left and right; the third microgram shows a dot with two lines that far apart to the dots at the upper left and upper right; and the fourth micrograph shows a dot at the bottom with lines extending to dots to the upper left and right in a “U”shape. All data are approximate.
Proteins in the SMC family are found in all types of organisms, from bacteria to humans. Eukaryotes have two major types, cohesins and condensins, both of which are bound by regulatory and accessory proteins (Fig. 24-31c, d). Cohesins play a substantial role in linking together sister chromatids immediately after replication and keeping them together as the chromosomes condense to metaphase. This linkage is essential if chromosomes are to segregate properly at cell division. Cohesins, along with a third protein, kleisin, are thought to form a ring around the replicated chromosomes that ties them together until separation is required. The ring may expand and contract in response to ATP hydrolysis. Condensins are essential to the condensation of chromosomes as cells enter mitosis. In the laboratory, condensins bind to DNA in a manner that creates positive supercoils; that is, condensin binding causes the DNA to become overwound, in contrast to the underwinding induced by the binding of nucleosomes. A model for the role of condensins in chromatin compaction is presented in Figure 24-32. In brief, as DNA is compacted to form tighter and tighter loops, the condensins stabilize the loops by binding at the base of each one. Cohesins and condensins are essential in orchestrating the many changes in chromosome structure during the eukaryotic cell cycle (Fig. 24-33).
A blue horizontal strand labeled chromatin has four rings of condensing around it, spread out from the left to the right. Each condensin has a curved green top and a curved purple bottom that meet at each end with a vertical oval on the left and a horizontal oval on the right. Each oval is green on top and purple on the bottom. An arrow points down accompanied by text with an orange oval labeled A T P next to the word hydrolysis. This leads to a stage labeled intramolecular chromosome looping, in which the blue strand has with four molecules across it. Each molecule has an oval above the blue strand with a green strand hanging down to the left to a green half circle and a purple strand hanging down to the right to a purple half circle. The ovals are vertical and are green on the left and purple on the right. Arrows point down to the left and right and are labeled A T P binding. The next stage is labeled fiber. The left-hand product shows a similar structure in which the purple half ovals on the right have joined to the green half ovals on the left beneath the blue strand. The blue strand has formed three loops in between the ovals above the blue strand. The right-hand arrow points to a structure in which the green and purple half-ovals of the same molecules have joined to form three loops labeled rings and the blue strand has formed loops around the top ovals of each molecule. Arrows labeled prophase point down from each side to show the rosettes that are formed. The left-hand rosette has green and purple ovals that each have a purple strand that runs down to join a green half-circle with a green strand up to the next oval, from which a purple strand runs down to repeat the process. Blue loops are present in between the ovals from which these green and purple strands extend. An arrow pointing down from this rosette is labeled metaphase and shows a string of three of these structures ranging from larger on the left to smaller on the right. The free end of the blue strand is located at the lower right and in the rosette and this strand and the other free ends fold across the three rosettes joined together after metaphase. The right-hand rosette is similar except that the ovals on the outside of the ring are located within the blood loops and the opening in the blue strand is on the left. An arrow labeled metaphase points down. This produces a structure in which the largest rosette is on the right and the smallest rosette is on the left with the blue strand from the right-hand rosette extending left along with the other free ends into the other rosettes to interact.
The stages of the cell cycle are labeled from left to right across the top as G 1, S, G 2, prophase, metaphase, anaphase/telophase, and G 1. On the left under G 1, a vertical blue chromosome is shown with a yellow oval centromere near the center. As the S phase begins, two loops labeled cohesion are added. These are shown as loops with one purple strand and one green strand, a vertical oval at one end that is green on the side with the green strand and purple on the side with the purple strand, and a sphere at the other end that is green on the side with the green strand and purple on the side with the purple strand with two orange ovals attached and connected by a strand, with one oval on each half of the sphere. This yields a similar strand with two cohesin molecules looped across the top half above the centromere and two cohesin molecules looped across the bottom half beneath the centromere. An arrow points right to show the addition of two more cohensin molecules. This yields a similar molecule with five cohensins above and five cohensins below. The D N A molecule has begin to separate, so four of the cohensins of each half are around separated strands of D N A (a dark blue strand and a new light blue strand) while the remaining two closest to the centromere are around a single blue strand. Replication occurs. An arrow points right to show the formation of two vertical strands of D N A that each have a centromere and are held together by four cohensins above and four cohesins below the centromere. During G 2, an arrow shows that three dots labeled condensing are added. At the start of prophase, dark blue ovals extend up and down from the left-hand centromere and light blue ovals extend up and down from the right-hand centromere. Four cohesins still hold together each half and the bottom half. Black dots representing condensing are visible above each cohesin on each half (one on the dark blue half and one on the light blue half). Three more condensins are added prior to metaphase. As metaphase begins, the same structure is shown but is smaller and now has two black condensins placed vertically above each condensin on each half (the dark blue half and the light blue half). Late in metaphase, an arrow labeled blue highlighted separase is accompanied by an arrow showing the loss of two open cohesins (no longer forming rings). During anaphase and telophase, the dark and light blue parts are separate. Each has a centromere and seven dots representing condensin above and below the centromere. An arrow points right at the end of anaphase/telophase with a branched arrow showing the loss of three dots. This yields similar but larger structures with only four black dots each during G 1. An arrow points right with a branched arrow to show the loss of three condensing to yield two horizontal blue lines, one dark blue and one light blue, that each have a centromere in the middle and that do not have any cohesin or condensing.
We now turn briefly to the structure of bacterial chromosomes. Bacterial DNA is compacted in a structure called the nucleoid, which can occupy a significant fraction of the cell volume (Fig. 24-34). The DNA seems to be attached at one or more points to the inner surface of the plasma membrane. Much less is known about the structure of the nucleoid than of eukaryotic chromatin, but a complex organization is slowly being revealed. In E. coli, a scaffoldlike structure seems to organize the circular chromosome into a series of about 500 looped domains, each encompassing, on average, 10,000 bp (Fig. 24-35), as described above for chromatin. The domains are topologically constrained; for example, if the DNA is cleaved in one domain, only the DNA within that domain will be relaxed. The domains do not have fixed end points. Instead, the boundaries are most likely in constant motion along the DNA, coordinated with DNA replication.
Bacterial DNA does not seem to have any structure comparable to the local organization provided by nucleosomes in eukaryotes. Histonelike proteins are abundant in E. coli — the best-characterized example is a two-subunit protein called HU — but these proteins bind and dissociate within minutes, and no regular, stable DNA-histone structure has been found. The dynamic structural changes in the bacterial chromosome may reflect a requirement for more ready access to its genetic information. The bacterial cell division cycle can be as short as 15 min, whereas a typical eukaryotic cell may not divide for hours or even months. In addition, a much greater fraction of bacterial DNA is used to encode RNA and/or protein products. Higher rates of cellular metabolism in bacteria mean that a much higher proportion of the DNA is being transcribed or replicated at a given time than in most eukaryotic cells.